Valiant Mauritius Partners trimmed its stake in Zota Health Care Limited from 5.17% to 5.13%, selling 14,400 shares. The value of the shares sold is ₹1.94 Cr at ₹1349.70 apiece.
An Indian pharmaceutical manufacturer that produces and markets a diverse range of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. The company exports its portfolio across semi-regulated and regulated markets in Asia, Africa, Russia, and Latin America, serving healthcare needs in multiple emerging markets. Zota Health Care operates across multiple therapeutic categories and consumer health segments to cater to varied patient requirements globally.
Mauritius-based investment vehicle of Valiant Capital, a San Francisco hedge fund. Invests in listed Indian equities.
